While dexamethasone, a commonly used corticosteroid, is a standard treatment for severe COVID-19, the study found that it modestly inhibited the release of arginase-1 from neutrophils. This was ...

Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA ...

The landscape of pandemic response has been transformed, with new standards being set for clinical excellence. A new report looks at emerging therapies, trial insights, and the innovations shaping the ...

Dexamethasone: The Game-Changer The first true success of drug repurposing in treating COVID-19 came with the discovery that ...

The severe acute respiratory syndrome coronavirus 2 just keeps doing what it does oh-so-well: it just keeps mutating and mutating and mutating, resulting in more and more variants. Leading the ...

Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Unspecified B-Cell Lymphomas.